Medication that reaches the spot where it’s needed without placing strain on the rest of the body is no longer a vision of the future. Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) has successfully developed proteins that function like a shuttle and release medication directly in the place in the body where they are actually needed. The study could serve as a model and could enable targeted and tissue-specific administration of medication in future. The findings have been published in the renowned journal ‘Proceedings of the National Academy of Sciences’ (PNAS)*.
Using medication in a targeted manner and getting it to its point of action without damaging healthy tissue on the way is a key issue at the moment in pharmaceutical research. Staff at the FAU’s Chair of Biotechnology led by Prof. Dr. Yves Muller and lead author of the study Karin Schmidt have developed a new solution for this process. In collaboration with researchers from Friedrich-Schiller Universität Jena, they were able to demonstrate that a certain group of proteins can be restructured to form tissue-specific ‘shuttles’ for medication.
A computer-aided process developed by the Chair of Biotechnology and experiments in the laboratory were required in order to solve the difficult task of designing proteins in such a manner so as to allow substances (so-called legates) to be bound to them. The researchers used crystallography in particular for this purpose.
In a game of ‘ping pong’ between applications on the computer and the laboratory, the researchers successfully converted a protein of human origin called antichymotrypsin into proteins to which they could bind a well-known antibiotic (Doxycyclin) and a widely-used cytostatic drug (Doxorubicin) that is used for treating cancer and autoimmune diseases.
The bound medication is then released in the target tissue by splitting the shuttle protein with a so-called proteinase enzyme. The published study now provides experimental proof of the fact that the medication was bound to the proteins and how it was achieved and lays the foundation for more detailed investigation.
Potential future areas of application
Using the protein shuttles could enable medication to be used in lower doses in a targeted manner without major procedures and with fewer side effects. This would lower the impact of the medication on the rest of the body and other organs and enable the active ingredients in the drugs to be used more effectively.
‘We have a long and difficult path ahead of us before certain proteins can be used as shuttles in medical applications,’ says Prof. Dr. Yves Muller, who led the study. The first step is to further increase the binding affinity of the drugs to the shuttle proteins. ‘The key has to fit even more precisely into the keyhole,’ says Prof. Dr. Muller. The Chair of Biotechnology at FAU will be intensely involved with this project during the next few years.
The next step involves extending the project to clinical applied research. Experimental proof must then demonstrate that the mechanisms also work in tissue. However, the researchers are hopeful that their model study has the potential for developing directed shuttles for medication and could be groundbreaking for targeted and efficient administration of medication.
*The results of the research were published with the title ‘Design of an allosterically modulated doxycycline and doxorubicin drug-binding protein’ in the journal ‘Proceedings of the National Academy of Sciences’ (PNAS) https://doi.org/10.1073/pnas.1716666115.
Phone: +49 9131 8523073
Prof. Dr. Yves Muller
Phone: +49 9131 8523082
Dr. Susanne Langer | idw - Informationsdienst Wissenschaft
Elusive compounds of greenhouse gas isolated by Warwick chemists
18.09.2019 | University of Warwick
Study gives clues to the origin of Huntington's disease, and a new way to find drugs
18.09.2019 | Rockefeller University
Researchers from the Department of Atomically Resolved Dynamics of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg, the University of Hamburg and the European Molecular Biology Laboratory (EMBL) outstation in the city have developed a new method to watch biomolecules at work. This method dramatically simplifies starting enzymatic reactions by mixing a cocktail of small amounts of liquids with protein crystals. Determination of the protein structures at different times after mixing can be assembled into a time-lapse sequence that shows the molecular foundations of biology.
The functions of biomolecules are determined by their motions and structural changes. Yet it is a formidable challenge to understand these dynamic motions.
At the International Symposium on Automotive Lighting 2019 (ISAL) in Darmstadt from September 23 to 25, 2019, the Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology FEP, a provider of research and development services in the field of organic electronics, will present OLED light strips of any length with additional functionalities for the first time at booth no. 37.
Almost everyone is familiar with light strips for interior design. LED strips are available by the metre in DIY stores around the corner and are just as often...
Later during this century, around 2060, a paradigm shift in global energy consumption is expected: we will spend more energy for cooling than for heating....
Researchers from the Department of Atomically Resolved Dynamics of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg, the University of Potsdam (both in Germany) and the University of Toronto (Canada) have pieced together a detailed time-lapse movie revealing all the major steps during the catalytic cycle of an enzyme. Surprisingly, the communication between the protein units is accomplished via a water-network akin to a string telephone. This communication is aligned with a ‘breathing’ motion, that is the expansion and contraction of the protein.
This time-lapse sequence of structures reveals dynamic motions as a fundamental element in the molecular foundations of biology.
Two research teams have succeeded simultaneously in measuring the long-sought Thorium nuclear transition, which enables extremely precise nuclear clocks. TU Wien (Vienna) is part of both teams.
If you want to build the most accurate clock in the world, you need something that "ticks" very fast and extremely precise. In an atomic clock, electrons are...
10.09.2019 | Event News
04.09.2019 | Event News
29.08.2019 | Event News
18.09.2019 | Medical Engineering
18.09.2019 | Life Sciences
18.09.2019 | Physics and Astronomy